EASYCATH: Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04984967
Collaborator
(none)
116
2
37

Study Details

Study Description

Brief Summary

Peripheral venous catheterization represents the preferential option for term or preterm infant care in order to start drug treatment or hydration, or perform anesthesia.

However, the peripheral venous access is associated in approximately 50% of cases with a failure of the insertion on the first attempt in an emergency context. Using a micro-guide may facilitate the peripheral venous catheterization in newborns, by guiding the catheter in the vein and, thereby reduce the risk of transfixion of the vascular lumen.

Condition or Disease Intervention/Treatment Phase
  • Device: Insertion of peripheral venous catheter with micro-guide
  • Other: Classic insertion of peripheral venous catheter, without micro-guide
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
116 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Masking Description:
Peripheral venous catheterization is perform by a nurse. The placement characteristics are evaluated by the investigator, blind of the condition of placement if possible.
Primary Purpose:
Other
Official Title:
Comparison of Two Techniques of Peripheral Venous Catheterization in Newborns : Insertion on Micro-guide Versus Conventional Insertion, Without Micro-guide
Anticipated Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Insertion of peripheral venous catheter with micro-guide

Device: Insertion of peripheral venous catheter with micro-guide
After antisepsis, the vein is punctured using a needle. Then the micro-guide is inserted to the first landmark, which indicates the passage of the micro-guide beyond the end of the needle. After the needle removed, the peripheral venous catheter is placed on the micro-guide. The guide is then removed, the peripheral venous catheter can be used.

Other: Classic insertion of peripheral venous catheter, without micro-guide

Other: Classic insertion of peripheral venous catheter, without micro-guide
After antisepsis, the catheter is introduced into the vein by a needle which is subsequently removed while the catheter remains in place.

Outcome Measures

Primary Outcome Measures

  1. Success of peripheral venous catheterization at the first attempt [Up to 5 minutes after the success of the placement]

    The success of the placement is defined by the arrival of blood in the transparent chamber downstream of the needle during the placement, and by the absence of painful reaction and edema near the insertion site, indicating extravasation or extravascular passage, after flushing the catheter with 0.5 to 1 ml of isotonic saline. The success will be confirmed by retesting flush after securing the peripheral venous catheter in a dressing, within 3 to 5 minutes of successful puncture.

Secondary Outcome Measures

  1. Efficiency of the technique [Up to 4 days.]

    Assessed by the number of venipuncture attempts, the duration of the installation (time from the end of skin asepsis to the end of the occlusive dressing), the requirement to insert a central venous line directly linked to failure of peripheral venous catheterization, and the reason for removal of peripheral venous catheter (ie, elective removal or removal for the occurrence of adverse events, see below).

  2. Adverse events [Up to 4 days.]

    Specifically associated with the micro-guide: section, intravascular migration, venous transfixion.

  3. Adverse events [Up to 1 month.]

    Common to the placement of any peripheral venous catheter, regardless of the insertion technique : puncture of an artery, pain, hemorrhage at the puncture site, phlebitis, thrombosis, infection, obstruction and subcutaneous diffusion of the infusion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 28 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Newborn admitted in the department of neonatal medicine and pediatric intensive care, at Montpellier University Hospital
Exclusion Criteria:
  • Term neonate > 28 days

  • Premature neonate > 41 weeks of corrected gestational age

  • Exclusive requirement for an umbilical venous catheter, in the context of neonatal resuscitation

  • Exclusive requirement for an epicutaneous-cava catheter, in the context of prolonged parenteral nutrition.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04984967
Other Study ID Numbers:
  • RECHMPL20_0410
First Posted:
Aug 2, 2021
Last Update Posted:
Aug 2, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier

Study Results

No Results Posted as of Aug 2, 2021